Attach A Rev_OTP Survey clean

Attach A Rev_OTP Survey clean.docx

2011 Opioid Treatment Program (OTP) Survey

Attach A Rev_OTP Survey clean

OMB: 0930-0319

Document [docx]
Download: docx | pdf


Shape1 U.S. Department of Health and Human Services OMB No. xxx-xxxx

Approval Expires: xx/xx/xxxx

2011 Opioid Treatment Program (OTP) Questionnaire

March 31, 2011

Sponsored by the Substance Abuse and Mental Health Services Administration

(SAMHSA)





PLEASE REVIEW THE INFORMATION BELOW.


CROSS OUT ANY ERRORS AND ENTER THE CORRECT INFORMATION.






















PLEDGE TO RESPONDENTS


The information you provide will be protected to the fullest extent allowable under the Public Health Service Act, 42 USC Sec 501(n). This law permits the public release of identifiable information about an establishment only with the consent of that establishment and limits the use of the information to the purposes for which it was supplied. Facility data will be de-identified such that identifying individual treatment facilities from the published data will not be possible.



Shape2

PLEASE READ THIS ENTIRE PAGE

BEFORE COMPLETING THE QUESTIONNAIRE

I

Would you prefer to complete this questionnaire online?

See the neon green flyer enclosed in your questionnaire packet for the Internet address and your unique user ID and password. As with the N-SSATS survey, you can log on and off the website as often as needed to complete the questionnaire. When you log on again, the program will take you to the next unanswered question. If you need more information, call the OTP Survey helpline at 1‑888-324-8337.

NSTRUCTIONS

  • Many of the questions in this survey ask about “this Opioid Treatment Program (OTP).” By “this OTP” we mean the specific opioid treatment program whose name and location are printed on the front cover. If this OTP is part of a larger facility, report only about the services and activities at this OTP. If you have any questions about how “this OTP” applies to your facility, please call 1-888-324-8337

  • Return the completed questionnaire in the envelope provided. Please keep a copy for your records.

  • For additional information about this survey, please visit http://info.nssats.com.

  • If you have any questions please contact:

MATHEMATICA POLICY RESEARCH

1-888-324-8337


Shape3

SECTION A

OPIOID TREATMENT PROGRAM SERVICES AND CHARACTERISTICS


Section A asks about services and characteristics of this Opioid Treatment Program (OTP), that is, the OTP at the location listed on the cover of this survey. If this OTP is part of a larger facility, report only about the services and activities at this OTP.


A1. Is this OTP, at this location, normally scheduled to be open 365 days a year?


1 Yes

0 No



A2. Does this OTP have a plan or an agreement with another provider to provide continuity of care for patients during service disruptions, whether due to a major disaster or more routine event, such as a snowstorm?


1 Yes

Shape18 0 No Shape19 SKIP TO A3 (BELOW)



A2a. With which of the following providers does this OTP have such a plan or agreement?


MARK “YES” OR “NO” FOR EACH

YES NO

1. A hospital 1 0

2. Another OTP 1 0

3. A pharmacy 1 0

4. Other (Specify below: 1 0

)



A3. Does this OTP have a formal agreement for medical referral purposes with…


MARK “YES” OR “NO” FOR EACH

YES NO

1. A Federally Qualified Health

Center (FQHC) 1 0

2. A hospital 1 0

3. A medical clinic 1 0

4. Other (Specify below: 1 0

)


A4. Does this OTP have a written agreement (as provided in 42 CFR Part 2) that permits other health service providers to receive, process, store, or otherwise manage patient records?


1 Yes

0 No




A5. For each day of the week, record this OTP’s number of scheduled daily hours…


Column A – For dispensing methadone, buprenorphine (Subutex® or generic) or buprenorphine/naloxone (Suboxone®).


Column B – For counseling.


  • If not scheduled on a given day, record “0” hours for that activity on that day.



Column A

Column B

Days of Week

Total Number of Scheduled Hours for Dispensing

Medication

Total Number of Scheduled Hours for Counseling

Monday

__________

__________

Tuesday

__________

__________

Wednesday

__________

__________

Thursday

__________

__________

Friday

__________

__________

Saturday

__________

__________

Sunday

__________

__________




A6. Does the OTP, at this location, provide vaccinations for…


MARK “YES” OR “NO” FOR EACH

YES NO

1. Hepatitis B 1 0

2. Influenza 1 0


Shape48

A7. This question asks about screening and diagnostic tests provided at this OTP.


Column A – For which of these conditions does this OTP routinely screen? Consider all screening performed at intake, assessment or admission.

Column B – For which of these conditions does this OTP perform diagnostic tests? Consider all testing performed as medically appropriate.



Column A

Column B

Health Condition

Routinely Screen

Perform Diagnostic Tests


Yes

No

Yes

No

1. Diabetes

1

0

1

0

2. Hepatitis C

1

0

1

0

3. HIV/AIDS

1

0

1

0

4. Hypertension (high blood pressure)

1

0

1

0

5. Pregnancy

1

0

1

0

6. Heartbeat abnormalities

1

0

1

0

7. Sexually transmitted infections (STIs, including gonorrhea, syphilis)

1

0

1

0

8. Sleep apnea

1

0

1

0

9. Alcohol use

1

0

1

0

10. Tobacco use

1

0

1

0


A8. Does this OTP routinely test for any of the following drugs at admission?


MARK “YES” OR “NO” FOR EACH

YES NO

1. Marijuana 1 0

2. Cocaine 1 0

3. Benzodiazepines 1 0

4. Heroin 1 0

5. Prescription opioids 1 0

6. Methamphetamines 1 0

7. Other stimulants (Please specify: 1 0

)




A9. For each of the listed psychiatric conditions, please indicate if this OTP…


Column ARoutinely screens for the condition.

Column BProvides treatment involving medication.

Column CProvides treatment involving counseling therapy.



Column A

Column B

Column C

Psychiatric Condition

Routinely Screens

Treatment Involving Medication

Treatment Involving Counseling


Yes

No

Yes

No

Yes

No

1. Anxiety/Panic disorder

1

0

1

0

1

0

2. Bipolar disorder

1

0

1

0

1

0

3. Depression

1

0

1

0

1

0

4. Post traumatic stress disorder

1

0

1

0

1

0

5. Schizophrenia

1

0

1

0

1

0

6. Other (Specify below:

1

0

1

0

1

0

)


Shape49

A10. This question concerns the clinical staff providing patient services at this OTP in a typical week.


  • Please count a staff member in one category only.


Column A Please record total number employed at this OTP.


Column B – Please record the sum total hours worked for all staff listed in Column A in a typical week.



Column A

Column B

Clinical Staff

total number employed at this otp

(if none, enter “0”)

sum total number of hours worked in typical week

1. Physician (MD, DO, Psychiatrist, etc.)

______

______

2. Registered Nurse (RN)

______

______

3. Licensed Practical Nurse (LPN)

______

______

4. Mid-level medical personnel (Nurse Practitioner, PA, APRN, etc.)

______

______

5. Pharmacist

______

______

6. Doctoral level counselor (Psychologist, etc.)

______

______

7. Masters level counselor (MSW, etc.)

______

______

8. Other degreed counselor (BA, BS)

______

______

9. Associate degree or non degreed counselor

______

______



A11. For clinical management, does this OTP…


MARK “YES” OR “NO” FOR EACH

YES NO

1. Use in-house or proprietary software

(software that was created for, or

modified specifically for, this OTP

or facility)? 1 0

2 . Use commercially-available software

that has not been modified specifically

for this OTP or facility? 1 0

3. Use a paper system only (no computer/

electronic clinical management)? 1 0


A12. For each of the following activities, please indicate if staff members routinely use computer or electronic resources, paper only, or a combination of both to accomplish their work…



MARK ONE METHOD FOR EACH ACTIVITY

Work Activity

Computer/ Electronic Only

Paper Only

Both Electronic and Paper

1. Intake

1

2

3

2. Assessment

1

2

3

3. Treatment plan

1

2

3

4. Discharge

1

2

3

5. Referrals

1

2

3

6. Issue/Receive lab results

1

2

3

7. Billing

1

2

3

8. Outcomes management

1

2

3

9. Medication dispensing

1

2

3



A13. Do computers at this OTP have the capability to access the Internet?


1 Yes

Shape57 0 No Shape58 SKIP TO A14


Shape59

A13a. Does this OTP primarily access the Internet using…


1 A regular “dial-up” telephone line

2 DSL, cable modem, fiber optics, satellite,

wireless (such as Wi-Fi) or some other

broadband Internet connection?

3 Something else? (Specify below:

)



A14. Do any outpatients travel an hour or more, each way, to be treated at this OTP?


1 Yes

0 No

n Not applicable, no outpatient OTP patients

Shape60


S

For this survey, an OTP patient is a person who has been admitted to this OTP and who receives methadone or buprenorphine.

ECTION B: OTP PATIENT CHARACTERISTICS











QUESTION B1 REFERS ONLY TO NEW PATIENTS ADMITTED TO THIS OTP IN 2010.



B1. During the 2010 calendar year, how many new patients were admitted to this OTP?



ENTER A NUMBER

(IF NONE, ENTER “0”)

2010 CALENDAR YEAR

TOTAL BOX








Questions B2 – B6 ask about ALL patients in treatment at this OTP on March 31, 2011.



B2. On March 31, 2011, how many patients were in treatment at this OTP?



ENTER A NUMBER

(IF NONE, ENTER “0”)

MARCH 31, 2011

TOTAL BOX






B3. On March 31, 2011, how many of these OTP patients were…


  • Each category total should equal the number reported in the TOTAL BOX in B2.


ENTER THE NUMBER OF PATIENTS IN EACH CATEGORY

(IF NONE, ENTER “0”)

GENDER


Male


Female


Other, unknown or not collected


GENDER TOTAL: (Should=B2)





AGE


Under 18


18-34


35-54


55 and over


Unknown or not collected


AGE TOTAL: (Should=B2)





RACE & ETHNICITY


White


Black


Hispanic


Asian


American Indian or Alaska Native


Native Hawaiian or Other Pacific Islander


Two or more races


Unknown or not collected


RACE & ETHNICITY TOTAL: (Should=B2)





VETERAN STATUS


Veteran


Non Veteran


Unknown or not collected


VETERAN TOTAL: (Should=B2)




Shape61

B4. Of the patients in treatment on March 31, 2011, how many had been in treatment continuously at this OTP for


ENTER THE NUMBER OF PATIENTS

(IF NONE, ENTER “0”)


0-90 days

_______


91-180 days

_______


181-365 days

_______


More than 1 year to less than 2 years

_______


2 years or longer

_______


TOTAL (Should = B2)








B5. How many of the patients in treatment on March 31, 2011 were dispensed methadone?


Shape62 NONE, DO NOT DISPENSE METHADONE

SKIP TO B6



ENTER A NUMBER

(IF NONE, ENTER “0”)

NUMBER DISPENSED METHADONE






B5a. Of these patients, how many were receiving methadone for…


ENTER THE NUMBER OF PATIENTS

(IF NONE, ENTER “0”)


Maintenance

_______


Detoxification

_______


Total Receiving Methadone

(Should = B5)








B5b. How many methadone maintenance patients in B5a were receiving methadone doses of…


ENTER THE NUMBER OF PATIENTS

(IF NONE, ENTER “0”)


Less than 40 mg.

_______


40 to 79 mg.

_______


80 to 119 mg.

_______


120 mg. or above

_______


Total Receiving Methadone

(Should = B5)








B5c. How many of the patients in B5 had been receiving methadone for 2 years or more?



ENTER A NUMBER

(IF NONE, ENTER “0”)

NUMBER RECEIVING METHADONE FOR 2 YEARS OR MORE







B5d. Of the patients in B5c, how many were receiving take-home doses for the following number of days…


NUMBER OF DAYS

ENTER THE NUMBER OF PATIENTS

(IF NONE, ENTER “0”)


0 days (did not receive take-home doses)

_______


1-7 days

_______


8-14 days

_______


15-30 days

_______


Total Receiving Methadone for 2 years or more

(Should = B5c)









B6. How many of the patients in treatment on March 31, 2011 were receiving buprenorphine (Subutex® or generic) or buprenorphine/ naloxone (Suboxone®)?


Shape63 NONE, DO NOT DISPENSE BUPRENORPHINE

SKIP TO B7



ENTER A NUMBER

(IF NONE, ENTER “0”)

NUMBER DISPENSED BUPRENORPHINE OR BUPRENORPHINE/NALOXONE







B6a. Of these patients, how many were receiving buprenorphine for…


ENTER THE NUMBER OF PATIENTS

(IF NONE, ENTER “0”)


Maintenance

_______


Detoxification

_______


Total Receiving Buprenorphine

(Should = B6)







B6b. How many buprenorphine maintenance patients in B6a were receiving buprenorphine doses of



ENTER THE NUMBER OF PATIENTS

(IF NONE, ENTER “0”)


Dosage

Buprenorphine (Subutex® or Generic)

Buprenorphine/Naloxone (Suboxone®)


Less than 8 mg.

__________

__________


8 to 16 mg.

__________

__________


17 to 24 mg.

__________

__________


25 to 32 mg.

__________

__________


More than 32 mg.

__________

__________


TOTAL RECEIVING BUPRENORPHINE

(Should = B6)














B7. Who was primarily responsible for completing this form?


Name:

Title:

Phone Number: (_____) – ______ -

Fax Number: (_____) – ______ -

Email Address:



B8. PLEASE INDICATE ANY COMMENTS













Thank you for your participation. Please return this questionnaire in the envelope provided. If you no longer have the envelope, please mail this questionnaire to:



MATHEMATICA POLICY RESEARCH

ATTN: RECEIPT CONTROL - Project 06667-OTP

P.O. Box 2393

Princeton, NJ 08543-2393

Public burden for this collection of information is estimated to average 50 minutes per response including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to SAMHSA Reports Clearance Officer, Room 8-1099, 1 Choke Cherry Road, Rockville, MD 20857. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The OMB number for this project is xxxx-xxxx.


PREPARED BY MATHEMATICA POLICY RESEARCH

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Title2011 Opioid Treatment Program (OTP) Questionnaire
SubjectQuestionnaire
AuthorMelissa Krakowiecki, Matthew Anderson
File Modified0000-00-00
File Created2021-02-01

© 2024 OMB.report | Privacy Policy